While North America and Europe have long been skincare leaders, we're seeing huge growth in the Asia-Pacific region, with a 7-9% CAGR in skincare applications
Type 1 Diabetes and Severe Kidney Disease GLP-1 agonists were originally developed for type 2 diabetes, not type 1
We identified hundreds of shipments of semaglutide, tirzepatide, minoxidil, spironolactone, and rivaroxaban (Xarelto), along with widespread product-code mismatches that may reduce regulatory scrutiny
2022 study , can help reduce body weight by up to 14.9% when combined with a balanced diet
This compressed treatment pathway is now mirrored in Europe and Japan, shrinking the time from diagnosis to pharmacologic therapy and expanding the eligible population at scale